Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Y3RY
|
||||
| Former ID |
DIB005376
|
||||
| Drug Name |
R-1578
|
||||
| Synonyms |
RG-1578; RG-1578); MGluR2 antagonist (depression), Roche; MGluR2 antagonist (Alzheimer's disease/depression), Roche
|
||||
| Indication | Mood disorder [ICD10:F30-F39] | Discontinued in Phase 2 | [549263] | ||
| Company |
Abiocode; Hoffmann-La Roche AG
|
||||
| Target and Pathway | |||||
| Target(s) | Metabotropic glutamate receptor3 | Target Info | Antagonist | [551608] | |
| Metabotropic glutamate receptor 2 | Target Info | Antagonist | [551608] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Ionotropic glutamate receptor pathway | |||||
| Metabotropic glutamate receptor group II pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Metabotropic glutamate receptor group II pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.